Pain management prior authorization at Kaiser Permanente
PA workflow, documentation criteria, and peer-to-peer prep — for prescribers and PA staff
Kaiser Permanente pain management PA at a glance
Kaiser Permanente reviews pain management PA submissions against its medical policy library, with rules drawn primarily from CDC 2022 Opioid Prescribing Guideline + SAMHSA TIP-63 for MOUD. Kaiser Permanente-specific context: Integrated delivery system — care + insurance coordinated. California DMHC oversight is unique. CA IMR (Independent Medical Review) is a powerful external review track for Kaiser denials.
Documentation packet — what to send
- Pain diagnosis with ICD-10
- PDMP query result
- UDS where applicable
- Functional / PEG score baseline and follow-up
- Prior non-opioid trials with response
- For MOUD: SUD diagnosis + counselling plan
Common denial patterns to pre-empt
Patterns observed in pain management across payers, and where Kaiser Permanente's book of business overlaps:
- Opioid: MME daily limit exceeded (CDC recommendation)
- Opioid: PDMP query not documented
- Quantity limits and refill restrictions
- Non-opioid alternatives not tried
- Suboxone: SUD diagnosis without counselling-bundle requirement
Appeal angles when Kaiser Permanente denies
- CDC 2022 Opioid Prescribing Guideline (NOT the 2016 — superseded)
- PDMP query documented + UDS as appropriate
- Documented failure of non-opioid alternatives
- Functional improvement (PEG score) on prior regimen
Peer-to-peer prep
- Cite the 2022 CDC guideline (NOT 2016)
- Have PDMP query result and UDS on screen
- Document functional improvement (PEG score)
- For Suboxone: cite SAMHSA TIP-63 and explicitly disconnect access from counselling availability if that's the rejection lever
Drug-specific PA criteria at Kaiser Permanente
Deep dives on each drug's PA criteria at Kaiser Permanente:
Frequently asked questions
What documentation does Kaiser Permanente need for pain management prior authorizations?
Kaiser Permanente's PA packet for pain management typically includes: Pain diagnosis with ICD-10; PDMP query result; UDS where applicable; Functional / PEG score baseline and follow-up. CDC 2022 Opioid Prescribing Guideline + SAMHSA TIP-63 for MOUD citations strengthen the submission.
What's the turnaround at Kaiser Permanente?
Kaiser Permanente standard decision: 30 days. Expedited (urgent care): 72 hours per 45 CFR §147.136. Internal appeal window if denied: 180 days.
Which pain management drugs does Kaiser Permanente most often PA-restrict?
Top targets in pain management: buprenorphine, naltrexone. Each follows the per-drug step therapy + documentation requirements published in Kaiser Permanente's medical policy library.
How do I prep a peer-to-peer with Kaiser Permanente in pain management?
Cite the 2022 CDC guideline (NOT 2016) Have PDMP query result and UDS on screen Have the policy URL and the patient's chart open before the call.
Generate a Pain management PA packet
Open ApprovalHelp — generate a pain management PA packet tailored to Kaiser Permanente's criteria, with prescriber attestation and supporting citations pre-filled.
Get started →Contact: hello@approvalhelp.com